Metraipolis › archive › dc_d71858ef92e3

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42212863
DOI
10.2196/101366
License (as archived)
solo-consultazione
Archived
2026-10-09T06:58:27.164Z
SHA-256 of the archived text
b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2
Stable URL of this page
https://metraipolis.com/documento/dc_d71858ef92e3

How to cite

From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863 — Europe PMC (en), https://europepmc.org/article/MED/42212863 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d71858ef92e3 (Metraipolis archive dc_d71858ef92e3, sha256 b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2)
BibTeX
@misc{dcd71858ef92e3,
  title = {From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery — Europe PMC PMID:42212863},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42212863},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d71858ef92e3; sha256 b6214a9cf484c793569c16bbf4b7a120b161eb35b21bfca9b6a93769d0f799d2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212863. Agents can read the archived copy with the MCP tool read_document.